CalciMedica, Inc. (CALC) - Latest Market Data

Price & Market Data

Price: $0.64

Daily Change: +$0.01 / 1.56%

Daily Range: $0.615 - $0.65

Market Cap: $9,935,382

Daily Volume: 51,550

Performance Metrics

1 Week: -6.51%

1 Month: 3.67%

3 Months: 16.05%

6 Months: -79.85%

1 Year: -64.03%

YTD: -90.53%

About CalciMedica, Inc. (CALC)

A complete market overview for CalciMedica, Inc. (CALC). The stock is at 0.64, with a daily change of +$0.01 / 1.56%. Market cap: 9,935,382. Delve into its YTD and 3-month performance.

Company Details

Employees: 16

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Selected stocks

Gaia, Inc. (GAIA)

Playtika Holding Corp. (PLTK)

Organigram Global Inc. (OGI)

Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)